Stock listing
Coya Therapeutics, Inc.
Selected listing: COYA · NASDAQ · USD · US
Coya Therapeutics, Inc. (NASDAQ:COYA), Health Technology. Latest release Oct 5, 2026: Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3…
- Ticker
- NASDAQ:COYA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Coya Therapeutics, Inc.
Coya Therapeutics, Inc. is a public company traded under the ticker COYA in the American market. The company is committed to advancing its research and product pipeline to address unmet medical needs.
Latest news from Coya Therapeutics, Inc.
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
October 5, 2026
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
October 4, 2026
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
September 15, 2026
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
September 8, 2026
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
August 11, 2026
Research Coya Therapeutics, Inc.
Coya Therapeutics, Inc. company profile
View the public company page for Coya Therapeutics, Inc. on 6ix.
Coya Therapeutics, Inc. news
Read company news and market updates connected to Coya Therapeutics, Inc..
Coya Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Coya Therapeutics, Inc..